A. T. FIRATLI TUĞLULAR Et Al. , "Safety data of lenlidomide dexamethasone treatment in patients with relapsed refractory multiple myeloma in Turkey," 11.Balkan Hematoloji Günü , Turkey, 2016
FIRATLI TUĞLULAR, A. T. Et Al. 2016. Safety data of lenlidomide dexamethasone treatment in patients with relapsed refractory multiple myeloma in Turkey. 11.Balkan Hematoloji Günü , (Turkey).
FIRATLI TUĞLULAR, A. T., PEHLİVAN, M., SÖNMEZ, M., SARI, H. İ., SAYDAM, G., AYYILDIZ, M. O., ... ALİ, R.(2016). Safety data of lenlidomide dexamethasone treatment in patients with relapsed refractory multiple myeloma in Turkey . 11.Balkan Hematoloji Günü, Turkey
FIRATLI TUĞLULAR, AYŞE Et Al. "Safety data of lenlidomide dexamethasone treatment in patients with relapsed refractory multiple myeloma in Turkey," 11.Balkan Hematoloji Günü, Turkey, 2016
FIRATLI TUĞLULAR, AYŞE T. Et Al. "Safety data of lenlidomide dexamethasone treatment in patients with relapsed refractory multiple myeloma in Turkey." 11.Balkan Hematoloji Günü , Turkey, 2016
FIRATLI TUĞLULAR, A. T. Et Al. (2016) . "Safety data of lenlidomide dexamethasone treatment in patients with relapsed refractory multiple myeloma in Turkey." 11.Balkan Hematoloji Günü , Turkey.
@conferencepaper{conferencepaper, author={AYŞE TÜLİN FIRATLI TUĞLULAR Et Al. }, title={Safety data of lenlidomide dexamethasone treatment in patients with relapsed refractory multiple myeloma in Turkey}, congress name={11.Balkan Hematoloji Günü}, city={}, country={Turkey}, year={2016}}